176 related articles for article (PubMed ID: 25003606)
1. A novel method for simultaneous production of two ribosome-inactivating proteins, α-MMC and MAP30, from Momordica charantia L.
Meng Y; Lin S; Liu S; Fan X; Li G; Meng Y
PLoS One; 2014; 9(7):e101998. PubMed ID: 25003606
[TBL] [Abstract][Full Text] [Related]
2. Preparation of an antitumor and antivirus agent: chemical modification of α-MMC and MAP30 from Momordica Charantia L. with covalent conjugation of polyethyelene glycol.
Meng Y; Liu S; Li J; Meng Y; Zhao X
Int J Nanomedicine; 2012; 7():3133-42. PubMed ID: 22802682
[TBL] [Abstract][Full Text] [Related]
3. Mono-PEGylation of Alpha-MMC and MAP30 from Momordica charantia L.: Production, Identification and Anti-Tumor Activity.
Sun Y; Sun F; Li J; Wu M; Fan X; Meng Y; Meng Y
Molecules; 2016 Oct; 21(11):. PubMed ID: 27809255
[TBL] [Abstract][Full Text] [Related]
4. Α-MMC and MAP30, two ribosome-inactivating proteins extracted from Momordica charantia, induce cell cycle arrest and apoptosis in A549 human lung carcinoma cells.
Fan X; He L; Meng Y; Li G; Li L; Meng Y
Mol Med Rep; 2015 May; 11(5):3553-8. PubMed ID: 25573293
[TBL] [Abstract][Full Text] [Related]
5. Immunoaffinity purification of α-momorcharin from bitter melon seeds (Momordica charantia).
Yao X; Li J; Deng N; Wang S; Meng Y; Shen F
J Sep Sci; 2011 Nov; 34(21):3092-8. PubMed ID: 21994203
[TBL] [Abstract][Full Text] [Related]
6. MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis.
Chan DW; Yung MM; Chan YS; Xuan Y; Yang H; Xu D; Zhan JB; Chan KK; Ng TB; Ngan HY
Pharmacol Res; 2020 Nov; 161():105157. PubMed ID: 32814169
[TBL] [Abstract][Full Text] [Related]
7. Ribosome inactivating proteins (RIPs) from Momordica charantia for anti viral therapy.
Puri M; Kaur I; Kanwar RK; Gupta RC; Chauhan A; Kanwar JR
Curr Mol Med; 2009 Dec; 9(9):1080-94. PubMed ID: 19747115
[TBL] [Abstract][Full Text] [Related]
8. Ribosome-inactivating Protein MAP30 Isolated from
Zhou Y; Yang D; Qiang Z; Meng Y; Li R; Fan X; Zhao W; Meng Y
Recent Pat Anticancer Drug Discov; 2024; 19(2):223-232. PubMed ID: 36330636
[TBL] [Abstract][Full Text] [Related]
9. [Expression of recombinant ribosome inactivating protein MAP30 in E.coli and its biological activity].
Zhang LL; Ding Q; Zhan JB
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 May; 39(3):264-71. PubMed ID: 20544988
[TBL] [Abstract][Full Text] [Related]
10. Alpha-momorcharin (α-MMC) exerts effective anti-human breast tumor activities but has a narrow therapeutic window in vivo.
Cao D; Sun Y; Wang L; He Q; Zheng J; Deng F; Deng S; Chang S; Yu X; Li M; Meng Y; Jin J; Shen F
Fitoterapia; 2015 Jan; 100():139-49. PubMed ID: 25447153
[TBL] [Abstract][Full Text] [Related]
11. Expression and purification of a recombinant ELRL-MAP30 with dual-targeting anti-tumor bioactivity.
Chen WW; Zhang HR; Huang ZG; Zhou ZY; Lou QW; Jiang XY; Zhu ZH
Protein Expr Purif; 2021 Sep; 185():105893. PubMed ID: 33933613
[TBL] [Abstract][Full Text] [Related]
12. Balsamin, a novel ribosome-inactivating protein from the seeds of Balsam apple Momordica balsamina.
Kaur I; Yadav SK; Hariprasad G; Gupta RC; Srinivasan A; Batra JK; Puri M
Amino Acids; 2012 Aug; 43(2):973-81. PubMed ID: 22120616
[TBL] [Abstract][Full Text] [Related]
13. Ribosome-Inactivating Protein α-Momorcharin Derived from Edible Plant
Chen YJ; Zhu JQ; Fu XQ; Su T; Li T; Guo H; Zhu PL; Lee SK; Yu H; Tse AK; Yu ZL
Toxins (Basel); 2019 Nov; 11(12):. PubMed ID: 31779275
[TBL] [Abstract][Full Text] [Related]
14. Atomic-resolution structures of type I ribosome inactivating protein alpha-momorcharin with different substrate analogs.
Fan X; Wang Y; Guo F; Zhang Y; Jin T
Int J Biol Macromol; 2020 Dec; 164():265-276. PubMed ID: 32653369
[TBL] [Abstract][Full Text] [Related]
15. Alpha-momorcharin possessing high immunogenicity, immunotoxicity and hepatotoxicity in SD rats.
Meng Y; Liu B; Lei N; Zheng J; He Q; Li D; Zhao X; Shen F
J Ethnopharmacol; 2012 Jan; 139(2):590-8. PubMed ID: 22172326
[TBL] [Abstract][Full Text] [Related]
16. The MAP30 protein from bitter gourd (Momordica charantia) seeds promotes apoptosis in liver cancer cells in vitro and in vivo.
Fang EF; Zhang CZ; Wong JH; Shen JY; Li CH; Ng TB
Cancer Lett; 2012 Nov; 324(1):66-74. PubMed ID: 22579806
[TBL] [Abstract][Full Text] [Related]
17. Expression of Momordica charantia MAP30 and its antitumor effect on bladder cancer cells.
Hlin H; Zhi-Guo Z; Cong-Hui H; Yan Z; Qing L; Bo J; Hou-Guang H; Jun-Jie Z; Pei-Ying Z
Minerva Urol Nefrol; 2016 Jun; 68(3):275-81. PubMed ID: 25517785
[TBL] [Abstract][Full Text] [Related]
18. Alpha-momorcharin, a RIP produced by bitter melon, enhances defense response in tobacco plants against diverse plant viruses and shows antifungal activity in vitro.
Zhu F; Zhang P; Meng YF; Xu F; Zhang DW; Cheng J; Lin HH; Xi DH
Planta; 2013 Jan; 237(1):77-88. PubMed ID: 22983699
[TBL] [Abstract][Full Text] [Related]
19. [Study on the immunotoxicity of ribosome inhibiting protein of Momordica charantia].
Wan L; Meng YF; Shen FB; Zheng JC; Deng NH; Zhang LS
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 40(6):1033-7. PubMed ID: 20067114
[TBL] [Abstract][Full Text] [Related]
20. Alpha-momorcharin: a ribosome-inactivating protein from Momordica charantia, possessing DNA cleavage properties.
Wang S; Zheng Y; Yan J; Zhu Z; Wu Z; Ding Y
Protein Pept Lett; 2013 Nov; 20(11):1257-63. PubMed ID: 23777339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
